Search Results - "Salacata, A."

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial by Bohula, Erin A, Dwyer, Jamie P, Keech, Anthony, Brown, Conville, Nicolau, Jose Carlos, Ray, Kauski, Lee, A, Lehman, R, Proietto, J, Blombery, P, d'Emden, M, Fortin, C, Kouz, S, Teitelbaum, I, Berlingieri, J, Twum-Barima, D, Perez, L, Saavedra Guajardo, V, Bayram Llamas, E, Llamas Esperon, G, Scott, D, Elliott, J, Łanda, K, Stasiewski, A, Zytkiewicz-Jaruga, D, Witek, R, Wujkowski, M, Skórski, M, Laskowska-Derlaga, E, Claxton, E, Boccalandro, F, Guarnieri, T, Singal, R, Condit, J, Einhorn, D, Schlager, D, Schramm, E, Soufer, J, Chilka, S, Wallace-Wilding, K, Aronoff, S, Karim, A, Raisinghani, A, Portnay, E, Cornett, G, Benjamin, S, Diener, J, Barker, B, Baldari, D, Zhang, L, Shayani, S, Andrawis, N, Gabra, N, Ghitis, A, Sabatino, K, Browder, D, Karlsberg, R, Wiseman, A, Gonzalez-Campoy, JM, Chokshi, S, Felten, W, Kuvin, J, Talano, J, Desai, V, Chane, M, Baron, S, Concha, M, Peterson, P, Jones, D, Longshaw, K, Jennings, W, Viswanath, D, Weinstein, D, Estevez, R, Levin, P, McNeill, R, Kalen, V, Tami, L, Cohen, K, Saba, F, Brown, J, Gorman, T, Pueblitz, G, Rink, L, Krichmar, P, Cohen, A, Tan, A, Kotek, L, Duffy, B, Lewis, D, Alberton, A, Stich, M, Davis, M, Rosario, R, Brinson, C, Abadier, R, Morris, F, Perez, A, Rodriguez, H, Izquierdo, W

“…There is a direct relationship between bodyweight and risk of diabetes. Lorcaserin, a selective serotonin 2C receptor agonist that suppresses appetite, has…”
Get full text

Cephalosporin therapeutics for intensive care infections by Salacata, A, Chow, J W

“…Third generation cephalosporins are valuable agents in the ICU setting because of their broad spectrum of activity, in vitro potency against the Gram-negative…”
Get more information

16.28 by Mills, J., Juziuk, E., Salacata, A.

Get full text

16.28: Correlation of gated blood pool SPECT with contrast echocardiography in measuring left ventricular ejection fraction by Mills, J., Juziuk, E., Salacata, A.

Get full text

Visual Quantitative Estimation: Semiquantitative Wall Motion Scoring and Determination of Ejection Fraction by Lavine, Steven J., Salacata, Abraham

“…Ejection fraction (EF) is the most commonly used parameter of left ventricular (LV) systolic function and can be assessed by echocardiography. Quantitative…”
Get full text

Poster session 3: Implantation and follow up by Nowak, B., Misselwitz, B., Hero, M., Benkemoun, H., Moro, E., Marcon, C., Marras, E., Allocca, G., Delise, P., Drzewiecka, A., Kargul, W., Grzegorzewski, B., Wilczek, J., Malecka, B., Kutarski, A., Zabek, A., Segreti, L., Soldati, E., De Lucia, R., Zucchelli, G., Solarino, G., Barison, A., Sergi, D., Bongiorni, M. G., Di Cori, A., Petru, J., Neuzil, P., Sediva, L., Holy, F., Holdova, K., Vopalka, R., Kralovec, S., Taborsky, M., Andraos, A. W., Hussein, K. H., Aly, R., Elhusseiny, R., Elazab, A. B., Ragab, D., Battah, A. H., Nagy, H. K. H., Rucinski, P., Krzyzanowski, K., Zinka, E., Baszko, A., Alhous, H., Small, G. R., Hillis, G. S., Hannah, A., Broadhurst, P., Coluccia, G., Salacata, A., Gliwa, R., Keavey, S., Khan, J. N., Subramanian, V., Hee, C., Glancy, J. M., Prasad, N., Ploux, S., Deplagne, A., Wright, M., Sacher, F., Ritter, P., Haissaguerre, M., Clementy, J., Bordachar, P.

“…Abstract only…”
Get full text

Implantable Cardioverter Defibrillator Utilization Among Device Recipients Presenting Exclusively with Syncope or Near-Syncope by MILITIANU, ARIE, SALACATA, ABRAHAM, SEIBERT, KAREN, KEHOE, RICHARD, BAGA, JOHN J., MEISSNER, MARC D., PIRES, LUIS A., SCHUGER, CLAUDIO D., STEINMAN, RUSSELL T., MOSTELLER, ROBERT D., PALTI, AMOS J., BEN DAVID, JOSEPH, LESSMEIER, TIMOTHY J., LEHMANN, MICHAEL H.

“…ICD Use in Syncope. Introduction: Implantable cardioverter defibrillators (ICDs) are occasionally used in presumed high‐risk patients with…”
Get full text

Ventriculoatrial conduction capability and prevalence of 1:1 retrograde conduction during inducible sustained monomorphic ventricular tachycardia in 305 implantable cardioverter defibrillator recipients by Militianu, A, Salacata, A, Meissner, M D, Grill, C, Mahmud, R, Palti, A J, Ben David, J, Mosteller, R, Lessmeier, T J, Baga, J J, Pires, L A, Schuger, C D, Steinman, R T, Lehmann, M H

“…Despite the advent of dual chamber ICDs, differentiation of VT (SMVT) with 1:1 VA conduction will remain a challenge. In this study, VA conduction capability…”
Get full text